Halyard Health (HYH) Tops Q4 EPS by 7c

Halyard Health (NYSE: HYH) reported Q4 EPS of $0.57, $0.07 better than the analyst estimate of $0.50. Revenue for the quarter came in at $401 million versus the consensus estimate of $402 million.

GUIDANCE:

Halyard Health sees FY2016 EPS of $1.45-$1.65, versus the consensus of $1.60.

For earnings history and earnings-related data on Halyard Health (HYH) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance